Interestingly, acquired resistance to ALK TKI treatment in NB cells was found to be caused by a bypass mechanism involving the increased expression of growth arrest specific 6 (GAS6) and the concomitant activation of its cognate RTK, AXL [58]. Here, ALK is linked to neuroblastoma.